Health Economics

Financing the efficient delivery of medical services while reducing costs for consumers as well as health care providers is among the most challenging domestic policy problems many countries face. RAND addresses health economics issues through innovative, high-profile research in an effort to improve the efficiency of health care organizations, reduce costs for providers and consumers, and improve financing in health care markets.

Research conducted by: RAND Health; Bing Center for Health Economics; RAND Europe

Reports (42)

The Monetary Costs of Dementia in the United States — Apr 24, 2013

an elderly woman with a caretaker

Identifying the costs of dementia is challenging because persons who have it are likely to have co-existing chronic health problems, making isolating the costs among other costs difficult. Also, it is unclear how to attribute a monetary cost to informal caregiving.

The Economic Impact of Medicaid Expansion on Pennsylvania — Mar 28, 2013

The Affordable Care Act is a substantial reform of the U.S. health care insurance system. RAND researchers assessed the act’s potential economic effects on Pennsylvania, factoring in whether the state includes an expansion of Medicaid.

Hepatitis C: A projection of the healthcare and economic burden in the UK — Jan 11, 2013

Work presented in this report sought to assess the healthcare and economic burden of the hepatitis C virus (HCV) infection in the United Kingdom using a cohort simulation model.

The Economic Impact of the ACA on Arkansas — Jan 3, 2013

Arkansas flag

For Arkansas, the Affordable Care Act will result in an increase in GDP of around $550 million and the creation of about 6,200 jobs. The new law will also increase health insurance coverage by 400,000 newly insured individuals.

Evaluating Healthcare Coverage for U.S. Reserve Component Personnel — Jun 28, 2012

The military's TRICARE Reserve Select program offers reservists the option of purchasing health insurance through the military on terms that compare favorably with typical employer benefits, but the program does not appear to be effectively targeting those most likely to be uninsured.

A New Commercial Model for Big Pharma in the Postblockbuster World — Jun 8, 2012

The pharmaceutical industry can and should reconfigure its considerable resources to develop innovative and meaningful business models that are based on services that improve access and adherence to prescription drugs for common chronic conditions.

Ending Individual Mandate Would Cut Health Coverage, but Not Dramatically Hike Insurance Price — Feb 16, 2012

Eliminating a key part of health care reform that requires all Americans to have health insurance would sharply lower the number of people gaining coverage, but would not dramatically increase the cost of buying policies through new insurance exchanges.

More Transparency, Efficiency Needed to Improve Impact of HIV Funding in Developing Countries — Dec 14, 2011

With the need for HIV services in developing countries rising and the availability of funding flat or declining, existing resources should be better leveraged to help provide life-saving services to more people in need.

Addressing Medicare Payment Differentials Across Ambulatory Settings — Oct 12, 2011

bill payment calculator

Medicare's payment for physician work and malpractice liability expenses is the same regardless of where a service is provided, but payments differ for facility-related components of care.

Challenges to Value-Enhancing Innovation in Health Care Delivery: Commonalities and Contrasts with Innovation in Drugs and Devices — Oct 4, 2011

Discusses obstacles to steering innovation in health care toward activities that are worth their social costs and away from other innovative activities and considers drugs, devices, and delivery, with particular attention to delivery.

RAND/UCLA Quality-of-Care Measures for Carpal Tunnel Syndrome: Tools for Assessing Quality of Care and Appropriateness of Surgery — Aug 16, 2011

Offers two rigorously developed tools for assessing the quality of care received by patients with carpal tunnel syndrome and for determining whether surgery is necessary for individual patients.

Assessing the impacts of Revising the Tobacco Products Directive: Study to support a DG SANCO Impact Assessment — Mar 8, 2011

In order to inform the European Commission's formal Impact Assessment for a revision to the Tobacco Products Directive, this study provides an overview of evidence for tobacco product regulation and an analysis of health and economic implications.

Establishing State Health Insurance Exchanges: Implications for Health Insurance Enrollment, Spending, and Small Businesses — Aug 11, 2010

The Patient Protection and Affordable Care Act will increase insurance offer rates at small businesses. By 2016, rates would increase from 53 to 77 percent at firms with ten or fewer workers and from 71 to 90 percent at firms with 11 to 25 workers.

Extending U.S. Medicare to Mexico: Why It's Important to Consider and What Can Be Done — Jul 15, 2010

Explores the idea of allowing Medicare-eligible beneficiaries to use Medicare to cover health services received in Mexico.

Feasibility and Design Options for a Potential Entity to Research the Comparative Effectiveness of Medical Treatments — Jan 15, 2010

The options available to Massachusetts as it considers establishing a comparative effectiveness center to guide health care purchasing decisions are feasible, but design decisions depend on the prioritization of comparative effectiveness research.

Increase the Use of "Bundled" Payment Approaches — Jan 8, 2010

This document explores how increased use of bundled payment approaches would affect health system performance along nine dimensions.

Ease Medicaid/SCHIP Eligibility Rules — Jan 8, 2010

This document explores how expanding Medicaid/SCHIP eligibility would affect health system performance along nine dimensions.

Modify Federal Tax Code to Create Incentives for Individuals to Obtain Coverage — Jan 8, 2010

This document explores how a refundable tax credit to offset the cost of health insurance premiums would affect health system performance along nine dimensions.

Create or Expand Access to Purchasing Pools — Oct 12, 2009

This document explores how creating or expanding access to purchasing pools would affect health system performance along nine dimensions.

Physician Pay for Performance — Oct 12, 2009

This document explores how physician pay for performance (P4P) programs would affect health system performance along nine dimensions.

My RAND ?

Saved Items

Recommended